Marketing-authorisation holder
Marvel LifeSciences Ltd.
4 medicines in 1 country, as authorisation holder.
Medicines
Every medicine in the registers under its name, current ones first.
4 medicines
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Insulin Human 30/70 Mix Marvel | Insulin (human) | EU (EMA) | Refused | |
| Insulin Human Long Marvel | Insulin (human) | EU (EMA) | Refused | |
| Insulin Human Rapid Marvel | Insulin (human) | EU (EMA) | Refused | |
| Solumarv | Insulin (human) | EU (EMA) | Refused |
Countries
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| European Union (EMA) | 4 | 0 | 4 | CompaniesAll medicines |
Therapeutic areas
The ATC groups most of its medicines belong to, largest first.
- Drugs used in diabetesAlimentary tract and metabolism · ATC A10A
Top substances
The active substances in most of its medicines.
Names in the registers
How the registers spell it, normalised: legal forms, accents and capitals removed.
- marvel lifesciences
- marvel lifesciences ltd
Sources and licences
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Report an error or request removalCorrections from the company itself are welcome.
At a glance
- Type
- Marketing-authorisation holder
- Medicines
- 4
- Countries
- 1
- Roles
- Authorisation holder



